Generation of a PDK-1 knockout human embryonic stem cell line by CRISPR/(WAe009-A-2K) Cas9 editing

Amina Saleem1, Mingyu Wei2, Muhammad Khawar Abbas3

  • 1Anzhen Hospital, Capital Medical University, Beijing 100029, China; Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing 100029, China.

Stem Cell Research
|January 11, 2025
PubMed

Insights

Researchers created a knockout human embryonic stem cell line lacking Pyruvate Dehydrogenase Kinase1 (PDK1). This PDK1-KO hESC line is a valuable tool for studying PDK1

Area of Science:

  • Biochemistry and Molecular Biology
  • Stem Cell Biology
  • Cardiovascular Research

Background:

  • Pyruvate Dehydrogenase Kinase1 (PDK1) is a kinase regulating metabolic processes.
  • PDK1 is implicated in heart failure, associated with ventricular thinning and atrial/ventricular enlargement.

Purpose of the Study:

  • To explore the role of PDK1 in human heart development.
  • To generate a PDK1 knockout (PDK1-/-) human embryonic stem cell (hESC) line for research.

Main Methods:

  • Utilized an episomal vector-based CRISPR/Cas9 system for gene editing.
  • Developed a PDK1 knockout (PDK1-/-) human embryonic stem cell (hESC) line.

Main Results:

  • The PDK1-KO hESC line maintained stem cell-like morphology.
  • The cell line retained pluripotency and a normal karyotype.
  • Confirmed differentiation potential into all three germ layers in vivo.

Conclusions:

  • Successfully generated a viable PDK1-KO hESC line.
  • This cell line serves as a valuable tool for investigating PDK1's function in human heart development and related pathologies.